Evidence map›Paper›PMID 19699688›Full record

ArticleClinical immunology (Orlando, Fla.)2009

Oxidized lipids enhance RANKL production by T lymphocytes: implications for lipid-induced bone loss.

Lucia S Graham, Farhad Parhami, Yin Tintut, Christina M R Kitchen, Linda L Demer, Rita B Effros

Abstract read
In one paragraph

Article in Clinical immunology (Orlando, Fla.), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 95 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Obesity and lipid metabolism in the development of osteoporosis (Review).International journal of molecular medicine · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Association of dyslipidaemia with osteoporosis in postmenopausal women.The Journal of international medical research · 2021
    Article
  11. A Neutralizing Antibody Targeting Oxidized Phospholipids Promotes Bone Anabolism in Chow-Fed Young Adult Mice.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2021
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. The silent war of CMV in aging and HIV infection.Mechanisms of ageing and development · 2016
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Lucia S GrahamDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, 10833 Le Conte Avenue, Los Angeles, CA 90095-1732, USA.
Farhad Parhami
Yin Tintut
Christina M R Kitchen
Linda L Demer
Rita B Effros
University of California, Los Angeles · US

Funding

ULTRASTRUCTURE OF THE INTIMA IN EARLY LESION FORMATIONP01HL030568 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LUSIS, ALDONS JAKE · 1985 to 2019
$55.2M
RANKL/OPG-Mediated Control of Vascular CalcificationR01HL081202 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DEMER, LINDA L. · 2006 to 2010
$1.9M
CD8 T Cell Replicative Senescence: Impact on Aged HumansR01AG023720 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI EFFROS, RITA BRICKMAN · 2005 to 2009
$1.7M
CD8 T Cell Interaction with Bone Cells in HIV DiseaseR21AI056945 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI EFFROS, RITA BRICKMAN · 2004 to 2005
$462k
T Cell Replicative Senescence &Bone Loss During AgingR21AG024134 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI EFFROS, RITA BRICKMAN · 2004 to 2005
$343k
Minority Predoctoral Fellowship ProgramF31AG023838 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI GRAHAM, LUCIA · 2003 to 2008
$139k
NHLBI NIH HHS HL081202NHLBI NIH HHS HL30568NHLBI NIH HHS P01 HL030568NHLBI NIH HHS R01 HL081202NIAID NIH HHS AI056945NIAID NIH HHS R21 AI056945NIA NIH HHS AG023720NIA NIH HHS AG024134NIA NIH HHS F31 AG023838NIA NIH HHS F31AG023838NIA NIH HHS R01 AG023720NIA NIH HHS R21 AG024134
6 · The paper itself

Abstract

Osteoporosis is a systemic disease that is associated with increased morbidity, mortality and health care costs. Whereas osteoclasts and osteoblasts are the main regulators of bone homeostasis, recent studies underscore a key role for the immune system, particularly via activation-induced T lymphocyte production of receptor activator of NFkappaB ligand (RANKL). Well-documented as a mediator of T lymphocyte/dendritic cell interactions, RANKL also stimulates the maturation and activation of bone-resorbing osteoclasts. Given that lipid oxidation products mediate inflammatory and metabolic disorders such as osteoporosis and atherosclerosis, and since oxidized lipids affect several T lymphocyte functions, we hypothesized that RANKL production might also be subject to modulation by oxidized lipids. Here, we show that short term exposure of both unstimulated and activated human T lymphocytes to minimally oxidized low density lipoprotein (LDL), but not native LDL, significantly enhances RANKL production and promotes expression of the lectin-like oxidized LDL receptor-1 (LOX-1). The effect, which is also observed with 8-iso-Prostaglandin E2, an inflammatory isoprostane produced by lipid peroxidation, is mediated via the NFkappaB pathway, and involves increased RANKL mRNA expression. The link between oxidized lipids and T lymphocytes is further reinforced by analysis of hyperlipidemic mice, in which bone loss is associated with increased RANKL mRNA in T lymphocytes and elevated RANKL serum levels. Our results suggest a novel pathway by which T lymphocytes contribute to bone changes, namely, via oxidized lipid enhancement of RANKL production. These findings may help elucidate clinical associations between cardiovascular disease and decreased bone mass, and may also lead to new immune-based approaches to osteoporosis.

Indexed as

AnimalsBone DensityBone ResorptionCell NucleusDietary FatsDinoprostoneGene ExpressionHumansIsoprostanesLipidsLipoproteins, LDLMaleMiceMice, Inbred C57BLNF-kappa BOsteoprotegerin8-isoprostaglandin E2Dietary FatsDinoprostoneIsoprostanesLipidsLipoproteins, LDLNF-kappa BOLR1 protein, humanOsteoprotegerinoxidized-L-alpha-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholineoxidized low density lipoproteinPhosphatidylcholinesRANK LigandScavenger Receptors, Class ETNFSF11 protein, humanTranscription Factor RelA

Identifiers

PMID19699688
PMCPMC2805272
OpenAlexW2081480490

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.